Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 405,278 | 1,757,090 | 1,276,067 | 786,421 | 401,751 |
| Depreciation Amortization | 215,103 | 831,312 | 650,839 | 413,654 | 202,385 |
| Income taxes - deferred | -10,014 | -229,503 | -54,199 | 3,094 | -18,249 |
| Accounts receivable | -581,112 | -97,485 | -42,522 | 65,003 | -276,650 |
| Accounts payable and accrued liabilities | 110,728 | -124,757 | -37,181 | -46,866 | -2,267 |
| Other Working Capital | -527,181 | 1,367,497 | 983,344 | 543,090 | -472,948 |
| Other Operating Activity | 332,120 | -1,026,750 | -820,889 | -606,739 | 346,717 |
| Operating Cash Flow | $-55,078 | $2,477,404 | $1,955,459 | $1,157,656 | $180,739 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -268,446 | -950,848 | -721,615 | -426,845 | -207,884 |
| Net Acquisitions | -222,786 | -169,891 | -466,742 | -376,182 | -170,418 |
| Investing Cash Flow | $-491,233 | $-1,120,739 | $-1,188,358 | $-803,026 | $-378,302 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 369,479 | 639,835 | 650,222 | 599,214 | 277,208 |
| Debt Issued | 130,171 | 658,186 | 686,368 | 2,470 | 2,188 |
| Debt Repayment | -18,471 | -1,242,572 | -1,169,836 | -79,453 | -31,201 |
| Common Stock Issued | 691 | 53,792 | 45,954 | 37,118 | 4,727 |
| Common Stock Repurchased | N/A | -65,487 | N/A | N/A | N/A |
| Dividend Paid | N/A | -332,278 | -345,507 | -323,429 | N/A |
| Other Financing Activity | -66,599 | -614,167 | -519,529 | -501,936 | -96,920 |
| Financing Cash Flow | $415,271 | $-902,692 | $-652,327 | $-266,016 | $156,003 |
| Exchange Rate Effect | -30,884 | -149,666 | -90,848 | -75,301 | 738 |
| Beginning Cash Position | 1,202,292 | 801,249 | 833,149 | 779,912 | 755,456 |
| End Cash Position | 1,040,368 | 1,105,557 | 857,076 | 793,224 | 714,632 |
| Net Cash Flow | $-161,924 | $304,307 | $23,927 | $13,312 | $-40,824 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,078 | 2,477,404 | 1,955,459 | 1,157,656 | 180,739 |
| Capital Expenditure | -272,251 | -1,067,523 | -743,177 | -444,361 | -210,527 |
| Free Cash Flow | -327,329 | 1,409,881 | 1,212,282 | 713,295 | -29,788 |